Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.

Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.

Bibliographic Details
Main Authors:	Sooriakumaran, P, Spahn, M, Wiklund, P
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
by: Stephenson, A, et al.
Published: (2006)

Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence
by: Sushentsev, N, et al.
Published: (2023)

Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers.
by: Hugosson, J, et al.
Published: (2001)

Radical therapy may reduce mortality in men with metastatic prostate cancer
by: Sooriakumaran, P, et al.
Published: (2014)

Reply from authors re: Anders Bjartell "a robot saved my life": Is it a myth? Eur Urol 2012;62:775-6: The debate on the oncologic safety of robotics in prostate cancer is over: Time to move on
by: Sooriakumaran, P, et al.
Published: (2012)

Future prospects: who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches?
by: Ayres, B, et al.
Published: (2013)

Management of prostate cancer. Part 1: chemoprevention.
by: Sooriakumaran, P
Published: (2006)

Apples and oranges revisited : contextualized comparisons and the study of comparative labor politics
Published: (2003)

Apples and oranges? Comparing unconventional computers
by: Blakey, E
Published: (2010)

Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization
by: Peterson, R, et al.
Published: (2019)

Re: Effect of dutasteride on the risk of prostate cancer
by: Sooriakumaran, P, et al.
Published: (2010)

Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy.
by: Tewari, A, et al.
Published: (2012)

Updates on molecular and biochemical development and progression of prostate cancer
by: Fahmy, Omar, et al.
Published: (2021)

Lifestyle, biochemical, and genetic risk factors for prostate cancer
by: Byrne, K
Published: (2017)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
by: Steuber, T, et al.
Published: (2007)

Recurrent neural networks for Apple stock price prediction
by: Huang, Melville Bin
Published: (2023)

Endorectal MRI: Use in Prostate Cancer
by: Srivastava, A, et al.
Published: (2012)

Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy.
by: Khaksar, S, et al.
Published: (2006)

Apples & oranges? Comparing unconventional computers
by: Blakey, E
Published: (2010)

Clinically relevant fatigue in recurrence-free prostate cancer survivors.
by: Storey, D, et al.
Published: (2012)

Management of prostate cancer. Part 3: metastatic disease.
by: Shah, J, et al.
Published: (2006)

Angiogenesis and the tumour hypoxia response in prostate cancer: a review.
by: Sooriakumaran, P, et al.
Published: (2005)

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.
by: Sooriakumaran, P, et al.
Published: (2014)

The oncologic role of local treatment in primary metastatic prostate cancer.
by: Ghadjar, P, et al.
Published: (2014)

Minimally invasive surgical modalities in the management of localized prostate cancer.
by: Jamal, K, et al.
Published: (2008)

Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
by: Sooriakumaran, P, et al.
Published: (2012)

Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
by: Kelly, R. S., et al.
Published: (2018)

Energy efficiency, primary energy, and apples vs. oranges
by: Lienhard, John H
Published: (2019)

Smarter screening for prostate cancer: for the few, not the many? A stratified approach based on baseline risk.
by: Sooriakumaran, P
Published: (2011)

Metformin and prostate cancer: a new role for an old drug
by: Whitburn, J, et al.
Published: (2017)

Prostate volume and its correlation with histopathological outcomes in prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2011)

Management of prostate cancer. Part 2: localized and locally advanced disease.
by: Sooriakumaran, P, et al.
Published: (2006)

The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review.
by: Sooriakumaran, P, et al.
Published: (2005)

Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study
by: Bryant, R, et al.
Published: (2018)

The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years.
by: Sooriakumaran, P, et al.
Published: (2015)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
by: Hamdy, F, et al.
Published: (2006)

Endpoint security /
by: 215290 Kadrich, Mark
Published: (2007)

Robotic HIFU for the treatment of prostate cancer
by: Ng, Choong Kheng
Published: (2008)

Quality of evidence for treatment of prostate cancer.
by: Clarke, M
Published: (2000)

Methods of endpoint detection for isolated word recognition
by: Lamel, Lori Faith
Published: (2005)